Darryl Cleary
Monsanto
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Darryl Cleary.
Phosphorus Sulfur and Silicon and The Related Elements | 1993
James A. Sikorski; Michael J. Miller; Diane Susan Braccolino; Darryl Cleary; Susan D. Corey; Jose L. Font; Kenneth J. Gruys; C.Y. Han; Ko-Chung Lin; Paul D. Pansegrau; Joel E. Ream; Dora M. Schnur; Ajit S. Shah; Mark C. Walker
Abstract Novel aromatic bisubstrate inhibitors of the enzyme EPSP (5-enolpyruvoylshikimate-3-phosphate) synthase (EC 2.5.1.19) have been designed and synthesized as structural analogs of the single, catalytic intermediate 1 utilized by the enzyme. These aromatic inhibitors incorporate novel α-hydroxyphosphonates, malonate ethers and α-hydroxymalonates as replacements for the hydrolytically labile 3-phosphate group. These 3-phosphate mimics were much preferred to the corresponding methylene and vinylic phosphonates, malonates and phosphonomethyl ethers.
Bioorganic & Medicinal Chemistry Letters | 1993
Michael J. Miller; Karen S. Anderson; Diane Susan Braccolino; Darryl Cleary; Kenneth J. Gruys; C.Y. Han; Ko-Chung Lin; Paul D. Pansegrau; Joel E. Ream; R. Douglas Sammons; James A. Sikorski
Abstract Studies using alternate substrates, inhibitor product mimics and new derivatives of 4,5-dideoxy-shikimate-3-phosphate (ddS3P) are reported which indicate that the 3-phosphate group contributes significantly to substrate and inhibitor recognition at the shikimate 3-phosphate (S3P) site and that 3-malonate ethers will function as suitable 3-phosphate replacements for substrate and inhibitor binding to the S3P site of this enzyme.
Bioorganic & Medicinal Chemistry | 1995
Michael J. Miller; Darryl Cleary; Joel E. Ream; Kristin R. Snyder; James A. Sikorski
A new analog of the EPSP synthase enzyme reaction intermediate 1, containing a 3-malonate ether moiety in place of the usual 3-phosphate group, was synthesized from 3,5-dihydroxybenzoic acid. This simple, synthetically accessible aromatic compound (5) is an effective competitive inhibitor versus S3P with an apparent Ki of 1.3 +/- 0.22 microM. This result demonstrates that a simple benzene ring can be a suitable achiral substitute for the more complex shikimate ring in the design of EPSP synthase inhibitors. Furthermore, the greater potency of 5 versus the phenol 6, glycolate 7 and the gallic acid analog 8 demonstrates the requirement for multiple anionic charges at the dihydroxybenzoate 5-position in order to attain effective inhibition of this enzyme. However, this 3-malonate ether substituted compound was at least 10-fold less effective as a bisubstrate inhibitor than the corresponding 3-phosphate. This suggests that tetrahedral intermediate mimics possessing a 3-malonate ether moiety are less effective than their corresponding 3-phosphates in accessing the optimal enzyme conformation stabilizing 1.
Archive | 1990
James A. Sikorski; Karen S. Anderson; Darryl Cleary; Michael J. Miller; Paul D. Pansegrau; Joel E. Ream; R. Douglas Sammons; Kenneth A. Johnson
The herbicide markets of the late 1990’s and beyond will demand high performance products with stringent environmental acceptability requirements. We have initiated a multi-disciplinary herbicide discovery program directed toward the inhibition of key plant enzymes as one approach to meet these challenges. Plants contain a variety of biosynthetic pathways which are essential for their growth. Effective, plant-specific enzyme inhibitors offer the opportunity to satisfy the herbicide performance needs of the marketplace while exhibiting favorably low mammalian toxicity properties.1 Our enzyme-targeted research effort systematically integrates mechanistic biochemistry, molecular biology, modeling, inhibitor recognition, and structural biology information with organic synthesis through a series of collaborations within and outside Monsanto. A thorough understanding of the chemical mechanism for a particular enzyme target is an essential first step for the design of potent inhibitors.
Journal of Organic Chemistry | 2009
Peiyuan Wang; Byoung-Kwon Chun; Suguna Rachakonda; Jinfa Du; Noshena Khan; Junxing Shi; Wojciech J. Stec; Darryl Cleary; Bruce S. Ross; Michael J. Sofia
Bioorganic & Medicinal Chemistry Letters | 2000
Andrew Spaltenstein; Merrick R. Almond; William J Bock; Darryl Cleary; Eric S. Furfine; Richard J. Hazen; Wieslaw M. Kazmierski; Francesco Salituro; Roger D. Tung; Lois L. Wright
Journal of Organic Chemistry | 1992
Dennis Paul Phillion; Darryl Cleary
Archive | 2000
Darryl Cleary; Frank Waligora; Merrick R. Almond; Rose O'mahony; Terrence Mungal; Michael Kuzemko
Archive | 2003
Marcos L. Sznaidman; George R. Painter; Merrick R. Almond; Darryl Cleary; Amir Pesyan
Archive | 2005
Liotta Dennis C; Painter George R; Merrick R. Almond; Darryl Cleary; Jose Soria; Luis Sznaidman Marcos